You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
European Biomaterials Market The report “The European Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The European Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Biomaterials Market The report “The Asian Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The Asian Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asia Microbiology Asian Microbiology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018. The report “Asian Microbiology Market forecast for 2018 “analyzes the market by two segments such as microbiology instruments and microbiology reagents. |
Upcoming |
|
|
North America Microbiology The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018. The report “North American Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents. |
Upcoming |
|
|
North American Microfluidics Market The North American Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $669 million in 2013 and is poised to grow at a CAGR of 17.4% to reach $1496 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
European Microfluidics The European Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $420 million in 2013 and is poised to grow at a CAGR of 15.2% to reach $852 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
Asian Microfluidics Market The Asian Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $369 million in 2013 and is poised to grow at a CAGR of 20.9% to reach $952 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
Europe Molecular Diagnostics Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $311.3 million in 2013 and is expected to reach $454.3 million by 2018, at a CAGR of 8.2% from 2013 to 2018. The report “European Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming |
|
|
Asia Molecular Diagnostics Asian Molecular Diagnostics market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $246.5 million in 2013 and is expected to reach $557.5 million by 2018, at a CAGR of 18.5% from 2013 to 2018. The report “Asian Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming |
|
|
North America Molecular Diagnostics The Americas commanded the largest share 42% of the Global Molecular Diagnostics Market at an estimated $2066.7 million in 2013 and are expected to reach $3221.4 million by 2018, at a CAGR of 9.7% from 2013 to 2018. The report “North American Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming |
|
|
North American Bioinformatics The North American Bioinformatics Market, by increasing funding by government and private organization, was pegged at $1.36 billion in 2013 and expected to be $ 4.05 billion by 2018, growing at a CAGR of 20.1% from 2012 to 2018. The report “The North American Bioinformatics Market forecast, 2012-2018” analyzes the Bioinformatics market into Bioinformatics knowledge management, Bioinformatics services, Bioinformatics platforms. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio. |
Upcoming |
|
|
North American Bio-MEMS Market The North American BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
European Bio-MEMS Market The European BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
Asian Bio-MEMS Market The Asian BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
European Bioinformatics The European Bioinformatics Market, is driven by increasing funding by government and private organization, was pegged at $ 761 million in 2012 and expected to be $ 2.3 billion by 2018, growing at a CAGR of 19.7% from 2012 to 2018. Europe is the second largest leader of the market, due to rising Government support and funding. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio. |
Upcoming |
|
|
Asia-Pacific Bioinformatics The Asia-Pacific Bioinformatics Market, is driven by increasing funding by government and private organization, was pegged at $ 580 million in 2012 and expected to be $ 2.19 billion by 2018, growing at a CAGR of 23.8% from 2012 to 2018. The report “The Asia-Pacific Bioinformatics Market forecast, 2012-2018” analyzes the Bioinformatics market into Bioinformatics knowledge management, Bioinformatics services, Bioinformatics platforms. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio. |
Upcoming |
|
|
North America Radioimmunoassays (RIA) The report “North American Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. |
Upcoming |
|
|
Asia-Pacific Radioimmunoassays (RIA) Radioimmunoassay accounted for about one-third of the share of the overall immunoassays market in 2013. The report “Asia-Pacific Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Europe Radioimmunoassays (RIA) Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “European Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Asia Foot & Ankle Orthopedic Implants and Devices The Asian foot & ankle implants and devices market is mainly driven by the aging population and the increasing prevalence of rheumatoid and osteoarthritis. The report analyzes the market of devices by 6 segments, namely, ankle fusion, total ankle replacement, sub-talar joint replacement, phalangeal implants, artificial tendons & ligaments, and musculoskeletal reinforcement. All the segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques The report also provides an extensive competitive landscaping of the leading companies operating in this market. The key players in the Asian foot & ankle devices market are Wright Medical (U.S.), De Puy Synthes (U.S.), Arthrex (U.S.), Integra (U.S.), Tornier (U.S.), Stryker (U.S.), Smith & Nephew (U.K.), Acumed (U.S.), Vilex (U.S.), Zimmer Holdings (U.S.), Biomet (U.S.), Bio-Pro (U.S.), among a large number of niche players such as Ortho-fix (U.S.), Ortho-Helix (U.S.), Small Bone Innovations (U.S.), and Mondeal (U.K.). |
Upcoming |
Healthcare
